Objective: To examine the impact of nonfat and low-fat phytosterol-enriched beverages on low-density lipoprotein (LDL) electrophoretic characteristics. Design: Double-blind, randomized, crossover, placebo-controlled dietary trial. Setting: Diets were prepared and consumed at the Mary Emily Clinical Nutrition Research Unit of McGill University. Analyses were performed at the Institute on Nutraceuticals and Functional Foods of Laval University. Subjects and intervention: In total, 15 moderately hypercholesterolemic persons consumed each of three experimental diets that each comprised a different beverage: nonfat placebo (NF control), nonfat with phytosterols (NFPS) or low-fat with phytosterols (LFPS). Participants consumed three beverages daily at meal time for a total of 1.8 g of phytosterols per day. Nondenaturing 2-16% polyacrylamide gradient gel electrophoreses were used to characterize LDL size characteristics. Results: The NFPS and LFPS beverage induced no significant changes in several features of the LDL size phenotype compared to the control diet. Conclusion: The consumption of phytosterol-supplemented nonfat and low-fat beverages is not associated with clinically meaningful changes in the LDL particle size phenotype.
Introduction
Phytosterols enriched foods have been shown to reduce dietary cholesterol absorption, and hence plasma total and low-density lipoprotein (LDL) cholesterol concentrations (Jones et al, 1999 (Jones et al, , 2000 . Phytosterols generally require fat vehicles for their solubilization due to their low water solubility and very slow rate of dissolution in physiological bile salt (Armstrong & Carey, 1987) . However, low-fatphytosterol supplements may appear as more adequate vehicles for a healthy diet. Few studies have shown that lowfat phytosterol enriched foods can significantly lower plasma total and LDL-cholesterol levels (Nestel et al, 2001; Volpe et al, 2001) . In some studies, the reduction with low-fat foods was of the same magnitude as oil-based products (Tikkanen et al, 2001; Matvienko et al, 2002; Mensink et al, 2002) .
There is a large body of evidence indicating that small, dense LDL are more atherogenic than are larger, less dense particles (Austin, 2000) . Only limited information exists concerning the effect of phytosterols on the LDL particle size phenotype (Pedersen et al, 2000; Matvienko et al, 2002; Charest et al, 2004) , and no study has examined the effect of low-fat and nonfat phytosterol-supplemented beverages on LDL size characteristics. The objective of this study was to examine and compare the effect of low-and nonfat-phytosterol-enriched beverages on several LDL electrophoretic characteristics.
Subjects and methods
Analyses were conducted as part of a study from which data on plasma lipid levels have already been reported (Jones et al, 2003) . Briefly, 15 healthy volunteers (nine men, six women), aged between 22 and 68 y, with LDL-cholesterol between 3.25 and 6.0 mmol/l, high-density lipoprotein (HDL) cholesterol above 0.8 mmol/l, triglycerides (TG) concentrations below 4.0 mmol/l and body mass index (BMI) between 22 and 32 kg/m 2 were recruited as described previously (Jones et al, 2003) . Individuals reporting a personal endocrine disorder, dyslipidemia, hypertension, familial sitosterolemia, gastrointestinal disorders, iliac bypass surgery, heart disease or unstable angina in the last 3 months prior to screening were excluded. Subjects were required to refrain from taking lipidlowering medication or phytosterols for 6 weeks before screening as well as during the various study phases, probucol in the year prior to screening or experimental medication 30 days prior to screening. All subjects gave informed written consent according to the requirements of the Human Ethical Review Committee of the Faculty of Agriculture and Environmental Sciences of McGill University.
The study was performed as a double-blind randomized, crossover placebo-controlled trial with three experimental phases (Jones et al, 2003) . Experimental phases consisted of 21 feeding day periods, each separated by a 4-week washout period where participants returned to their habitual ad libitum diets (Jones et al, 2003) .
During each experimental phase, subjects consumed a North American diet. Meals were prepared at the Mary Emily Clinical Nutrition Research Unit of McGill University for consumption on site of at least two of the three meals including breakfast. The other meal was available for take out. The Mifflin equation with an activity factor of 1.7 was used to estimate each subject's basal energy requirement (Mifflin et al, 1990) . Body weights were monitored daily during each diet cycle to ensure compliance and correct caloric intake, and food amounts were adjusted accordingly when necessary.
Three types of beverage, either nonfat placebo (NF control), nonfat with phytosterols (NFPS) or low-fat (1% fat by weight) with phytosterols (LFPS) were supplied (Jones et al, 2003) . Participants consumed daily three beverages of 100 ml at meal time. Each phytosterol-containing beverage portion provided 0.6 g of phytosterols, for a total of 1.8 g of phytosterols per day. Plant sterols in the low fat and zero fat beverages were dispersed by shaking vigorously the beverage bottles by hand to ensure that the sterols were well mixed.
Data on plasma lipid levels of this study have already been reported (Jones et al, 2003) . Nondenaturing 2-16% polyacrylamide gradient gel electrophoreses were used to characterize LDL particle size as previously described (St-Pierre et al, 2001) . The estimated diameter for the major peak in each scan was identified as the LDL peak particle size. The relative proportion of LDL having a diameter o255 Å (LDL% o255 Å ) was ascertained by computing the relative area of the densitometric scan o255 Å . A similar approach was used to assess the relative concentrations of cholesterol in particles with a diameter 4260 Å (LDL% 4260 Å and LDL-C 4260 Å ).
All data are expressed as means7s.e.m. Postdiet values in lipoprotein cholesterol, TG levels and LDL electrophoretic characteristics between treatments were compared using the least-squares mean test from the PROC MIXED procedure in SAS (version 8.1; SAS Institute Inc., Cary, NC, USA). Baseline levels were included as a covariate in all models and the Tukey test was used to adjust the P-value for multiple comparisons. Inclusion of a sex by treatment interaction term in the various models indicated that gender did not modulate the response to the experimental diets (not shown). Analyses of changes from baseline levels for each diet (not shown) yielded virtually identical results.
Results
The 15 subjects enrolled in the study completed the protocol. Therefore, complete data for all subjects were analyzed. The baseline characteristics of the study subjects are presented in Table 1 . As previously described (Jones et al, 2003) , body weight was unchanged across any of the three dietary phases. All three regimens were well tolerated without any reported adverse events.
As reported previously (Jones et al, 2003) , plasma LDLcholesterol concentrations decreased by 10.9% (Po0.01) and 8.1% (Po0.01) with the NFPS and LFPS beverages, respectively, compared to the baseline (not shown), but there was no significant difference in LDL-cholesterol levels (P ¼ 0.6) among treatment groups including NF control at day 21 (Table 2 ). There was also no significant difference in plasma HDL-cholesterol concentrations following the NFPS and LFPS diets compared to the control diet (P ¼ 0.4).
The baseline LDL characteristics in this sample of hypercholesterolemic subjects reflected a profile with medium-large LDL peak particle size (mean of 258.870.9 Å on the control diet) and with o24% of LDL% o255 Å and 447% of LDL% 4 260 Å . None of the changes in the electrophoretic characteristics of LDL in the NFPS and LFPS groups was statistically different from the NF control group (Table 2) . 
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Discussion
This strictly controlled dietary study is the first to compare the effects of nonfat and low-fat unesterified phytosterol enriched beverages on several LDL electrophoretic characteristics. Our data suggest that phytosterols, when provided in low and nonfat beverages, have very little impact on the LDL size phenotype, with changes that may be too subtle to be clinically significant. It remains possible that the 3-week treatment period was not long enough to induce significant reductions in plasma cholesterol levels and, therefore, modify LDL electrophoretic characteristics. However, we have shown previously that clinically meaningful redistribution of LDL from smaller to larger subfractions may occur in response to dietary manipulation even in the absence of significant modifications in total LDL-cholesterol levels . Subjects, in the present study, were characterized by a relatively favorable baseline LDL size profile and this may also have impeded any further change in the various LDL electrophoretic characteristics.
There is some controversy regarding the true efficacy of the cholesterol-lowering property of nonfat and low-fat phytosterol-enriched foods. In the present trial, phytosterols were incorporated into nonfat and 1% fat beverages. The explanation for the lack of effect of phytosterol enriched beverage on LDL-cholesterol levels has been reported and discussed extensively in a previous article (Jones et al, 2003) . Briefly, we hypothesized that the content of fat was not high enough to adequately solubilize phytosterols, thus explaining the relatively small reduction in total and LDL-cholesterol concentrations. Despite a daily dose of 1.8 g, a quantity determined to be sufficient to elicit a hypocholesterolemic response when dispersed in a fat vehicle (Hallikainen et al, 2000; Jones et al, 2000; Vanstone et al, 2002) , we did not observe a reduction in total and LDL-cholesterol concentrations. Consequently, the results of our study suggest that beverages may not be good vehicles for delivering phytosterols to effectively lower plasma total and LDL-cholesterol and modify LDL size electrophoretic characteristics.
We have shown in the Québec Cardiovascular Study (StPierre et al, 2001 ) that increased concentrations of cholesterol in the small LDL subfraction (LDL-C o255 Å ) were associated with an increase in the risk of coronary heart disease (CHD) even in the presence of relatively normal LDL-cholesterol levels. The effect of plant sterols on LDL particle size phenotype is still not well documented and understood. Matvienko et al (2002) have shown that phytosterols had no effect on LDL particle size phenotype, while Pedersen et al (2000) reported that the sterol content of rapeseed and sunflower oils had more favorable effects on blood lipids, LDL particle size, and lipid content of larger and mediumsize LDL subfractions compared with olive oil. We have recently shown that the consumption of sterols and stanols had very little impact on LDL particle size phenotype in hypercholesterolemics (Charest et al, 2004) .
Plasma TG levels are strongly correlated with increasing density and decreasing size of predominant LDL species (Lamarche et al, 1999) . In hypertriglyceridemic states, LDL are enriched with TG, thus becoming more susceptible to hydrolysis by intravascular lipolytic enzymes such as hepatic lipase (Lamarche et al, 1999) . LDL particle size is influenced by metabolic and dietary factors that affect plasma TG levels (Dreon et al, 1994; Krauss & Dreon, 1995) . Low-fat dietary interventions, at least those conducted under isocaloric conditions, have been shown to lower LDL-cholesterol by decreasing LDL particle size, particle number or both (Krauss & Dreon, 1995) . In the present study, one of the explanations for the lack of change in LDL particle size with phytosterol consumption may be the absence of change in plasma TG levels.
In conclusion, the results of this trial indicate that consumption of nonfat and low-fat phytosterol enriched beverages does not lead to important reductions in plasma LDL-cholesterol concentrations and does not elicit significant modifications of LDL electrophoretic characteristics. 
